Product Information

DEXLANSOPRAZOLE DR 60 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $3.8341 per EA under NDC 24979000206. Its NADAC has been published 199 times since Feb 1, 2023.

FDA first approved this application on Sep 16, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXLANSOPRAZOLE DR 60 MG CAP

dexlansoprazole
$3.8341per EA

Strength

60 mg/1

NDC

24979000206

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DEXLANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA202666

FDA Approved

9/16/2022

TE Code

AB

On Market Since

12/1/2022

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has been published 199 times since Feb 1, 2023, and over the history we have for it it has declined 45.9%. The table below summarizes its recorded NADAC range and movement.

Current price$3.8341 per EA
All-time high$7.3215 (Jul 12, 2023)
All-time low$3.6568 (Aug 19, 2026)
52-week high$4.3996
52-week low$3.6568
Median price$4.7587
Average price$5.3133
Largest weekly change-16.5% (Nov 20, 2024)
Weeks tracked199
Tracking sinceFeb 1, 2023

Price History

1W

+2.0%

1M

+3.4%

3M

+4.8%

6M

-2.7%

1Y

-12.9%

3Y

-47.3%

5Y

N/A

All

-45.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXLANSOPRAZOLE DR 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 60 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $3.8341 per EA (NDC 24979000206), effective Nov 18, 2026.

How has the price of DEXLANSOPRAZOLE DR 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has declined 45.9%. It has been tracked across 199 weekly CMS publications since Feb 1, 2023.

What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 60 MG CAP?

Since Feb 1, 2023, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has ranged from a low of $3.6568 (Aug 19, 2026) to a high of $7.3215 (Jul 12, 2023), with a median of $4.7587 per EA.

Are there cheaper alternatives to DEXLANSOPRAZOLE DR 60 MG CAP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXLANSOPRAZOLE DR 60 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXLANSOPRAZOLE DR 60 MG CAP?

DEXLANSOPRAZOLE DR 60 MG CAP (NDC 24979000206) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.